Trial reportHernia : the journal of hernias and abdominal wall surgery2026
Comparison of the effects of two drug combinations: ropivacaine-dexmedetomidine and ropivacaine-ketamine administered subcutaneously for postoperative pain control in patients with inguinal hernia: a double-blind clinical trial.
Trial report in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPostoperative pain management is a significant concern in surgery. This study aimed to compare the effects of two drug combinations, ropivacaine-dexmedetomidine and ropivacaine-ketamine, administered subcutaneously for postoperative pain control in patients undergoing inguinal hernia repair. MATERIALS AND
methodsIn this double-blind clinical trial, 140 patients scheduled for inguinal hernia surgery using the Lichtenstein technique at Valiasr Hospital in Arak were enrolled. They were randomly allocated into two treatment groups: dexmedetomidine + ropivacaine and ketamine + ropivacaine. The first group received dexmedetomidine 1 µg/kg plus ropivacaine 0.75% (3 mg/kg) diluted to a total volume of 10 mL with distilled water. The second group received ketamine 100 mg plus ropivacaine 0.75% (3 mg/kg) diluted to a total volume of 10 mL with distilled water. In both groups, subcutaneous injections were administered at the surgical incision site, which was then marked. Pain was assessed using the Visual Analog Scale (VAS) in the recovery room and at 2, 4, 6, 12, and 24 h postoperatively by a specialized surgical assistant. Changes in heart rate, mean arterial pressure, duration of analgesia, total opioid consumption, and complications were also recorded. Data were analyzed using SPSS version 20.
resultsThe mean pain score was significantly lower in the dexmedetomidine + ropivacaine group compared to the ketamine + ropivacaine group (P < 0.001). The mean duration of analgesia was significantly shorter in the ketamine + ropivacaine group (P = 0.001). The mean opioid consumption was significantly higher in the ketamine + ropivacaine group (P = 0.01).
conclusionDexmedetomidine, compared to ketamine, provides superior pain reduction, prolongs analgesia duration, and decreases opioid requirements following inguinal hernia repair using the Lichtenstein technique.
Indexed as
Identifiers
42274783What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.